[go: up one dir, main page]

SG43249A1 - Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture - Google Patents

Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture

Info

Publication number
SG43249A1
SG43249A1 SG1996006425A SG1996006425A SG43249A1 SG 43249 A1 SG43249 A1 SG 43249A1 SG 1996006425 A SG1996006425 A SG 1996006425A SG 1996006425 A SG1996006425 A SG 1996006425A SG 43249 A1 SG43249 A1 SG 43249A1
Authority
SG
Singapore
Prior art keywords
asmatic
pyrazinones
manufacture
processes
action
Prior art date
Application number
SG1996006425A
Other languages
English (en)
Inventor
Bernhard Dr Kutscher
Norbert Dr Hofgen
Thomas Dr Buchner
Ute Dr Achterrath-Tuckermann
Stefan Professor Dr Szelenyi
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of SG43249A1 publication Critical patent/SG43249A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1996006425A 1995-03-24 1996-03-21 Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture SG43249A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510965A DE19510965A1 (de) 1995-03-24 1995-03-24 Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
SG43249A1 true SG43249A1 (en) 1997-10-17

Family

ID=7757727

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996006425A SG43249A1 (en) 1995-03-24 1996-03-21 Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture

Country Status (30)

Country Link
US (1) US5723463A (no)
EP (1) EP0736532B1 (no)
JP (1) JP4124280B2 (no)
KR (1) KR100401395B1 (no)
CN (1) CN1058968C (no)
AR (1) AR002039A1 (no)
AT (1) ATE217624T1 (no)
AU (1) AU697908B2 (no)
BR (1) BR9601093A (no)
CA (1) CA2172472C (no)
CZ (1) CZ290784B6 (no)
DE (2) DE19510965A1 (no)
DK (1) DK0736532T3 (no)
ES (1) ES2174989T3 (no)
HR (1) HRP960129B1 (no)
HU (1) HUP9600731A3 (no)
IL (1) IL117621A (no)
MX (1) MX9601069A (no)
NO (1) NO307091B1 (no)
NZ (1) NZ286232A (no)
PL (1) PL184800B1 (no)
PT (1) PT736532E (no)
RU (1) RU2143433C1 (no)
SG (1) SG43249A1 (no)
SI (1) SI0736532T1 (no)
SK (1) SK36596A3 (no)
TR (1) TR199600217A2 (no)
TW (1) TW426682B (no)
UA (1) UA45319C2 (no)
ZA (1) ZA962270B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20012627A3 (cs) * 1999-01-20 2002-01-16 Arzneimittelwerk Dresden Gmbh Pouľití imidazo [1,5-a] pyrido [3,2-e]pyrazinonů jako léčiva
DE19961302A1 (de) * 1999-12-18 2001-06-21 Dresden Arzneimittel Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen
HU229439B1 (hu) 1999-08-21 2013-12-30 Takeda Gmbh Roflumilast és salmeterol szinergetikus kombinációja
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
AU2004226353A1 (en) 2003-04-01 2004-10-14 Laboratoires Serono Sa Inhibitors of phosphodiesterases in infertility
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
EP2489667B1 (en) * 2006-12-13 2015-04-15 ASKA Pharmaceutical Co., Ltd. Quinoxaline derivative
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
NZ584148A (en) * 2007-09-14 2011-05-27 Ortho Mcneil Janssen Pharm 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
KR101520086B1 (ko) 2007-09-14 2015-05-14 얀센 파마슈티칼스 인코포레이티드 1´,3´-이치환된-4-페닐-3,4,5,6-테트라히드로-2h,1´h-[1,4´]비피리디닐-2´-온
DK2200985T3 (da) 2007-09-14 2011-10-24 Ortho Mcneil Janssen Pharm 1,3-Disubstituerede 4-(aryl--X-phenyl)-1H-pyridin-2-oner
RU2492170C9 (ru) * 2007-11-14 2013-12-27 Орто-Макнейл-Янссен Фармасьютикалз, Инк. Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2
CA2706986A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-a) pyrazines as inhibitors of phosphodiesterase 10
EP2225248A1 (en) 2007-11-30 2010-09-08 Wyeth LLC Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
CN102186477B (zh) 2008-10-16 2013-07-17 奥梅-杨森制药有限公司 作为代谢型谷氨酸受体调节剂的吲哚和苯并吗啉衍生物
RU2512283C2 (ru) 2008-11-28 2014-04-10 Янссен Фармасьютикалз, Инк. Производные индола и бензоксазина в качестве модуляторов метаботропных глутаматных рецепторов
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439008B (zh) 2009-05-12 2015-04-29 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
ES2409006T3 (es) 2009-05-12 2013-06-24 Janssen Pharmaceuticals Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de los receptores mGluR2
CA2815002C (en) 2010-11-08 2019-10-22 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN103298810B (zh) 2010-11-08 2016-03-16 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
SG11201605742TA (en) 2014-01-21 2016-08-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
US5166344A (en) * 1989-05-31 1992-11-24 Berlex Laboratories, Inc. Process for the preparation of imidazoquinoxalinones
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
JP3147902B2 (ja) * 1991-06-14 2001-03-19 ファルマシア・アンド・アップジョン・カンパニー イミダゾ〔1,5−a〕キノキサリン
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
DE4228095A1 (de) * 1992-08-24 1994-03-03 Asta Medica Ag Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
JP3252484B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 4,5−ジヒドロ[1,2,4]トリアゾロ[4,3−a]キノキサリン誘導体の製造方法
JP3252483B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 3環性トリアゾロ誘導体の製造方法
DE4329970A1 (de) * 1993-03-31 1994-10-06 Basf Ag Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
FR2704547B1 (fr) * 1993-04-30 1995-06-09 Adir Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CA2162023A1 (en) * 1993-05-06 1994-11-24 Poul Jacobsen [1,2,4]triazolo[4,3-a]quinoxaline compounds, their preparation and use
CA2112290C (en) * 1993-12-23 2004-06-01 John R. Francis A clock recovery circuit for serial digital video
JP3240462B2 (ja) * 1996-05-24 2001-12-17 株式会社ケンウッド 光ディスク装置の光ピックアップサーボ装置

Also Published As

Publication number Publication date
PL184800B1 (pl) 2002-12-31
HUP9600731A3 (en) 1997-04-28
CZ74796A3 (en) 1996-10-16
BR9601093A (pt) 1998-01-06
DE59609201D1 (de) 2002-06-20
UA45319C2 (uk) 2002-04-15
ZA962270B (en) 1996-09-30
JP4124280B2 (ja) 2008-07-23
HU9600731D0 (en) 1996-05-28
SI0736532T1 (en) 2002-08-31
TR199600217A2 (tr) 1996-10-21
PL313434A1 (en) 1996-09-30
US5723463A (en) 1998-03-03
NO307091B1 (no) 2000-02-07
CZ290784B6 (cs) 2002-10-16
NO961173L (no) 1996-09-25
CN1058968C (zh) 2000-11-29
HRP960129B1 (en) 2002-12-31
AR002039A1 (es) 1998-01-07
IL117621A0 (en) 1996-07-23
HUP9600731A2 (en) 1997-01-28
CA2172472A1 (en) 1996-09-25
KR100401395B1 (ko) 2003-12-24
ATE217624T1 (de) 2002-06-15
NO961173D0 (no) 1996-03-22
RU2143433C1 (ru) 1999-12-27
CA2172472C (en) 2000-01-18
MX9601069A (es) 1997-02-28
AU4825796A (en) 1996-10-03
KR960034204A (ko) 1996-10-22
HRP960129A2 (en) 1997-08-31
ES2174989T3 (es) 2002-11-16
EP0736532A1 (de) 1996-10-09
DE19510965A1 (de) 1996-09-26
PT736532E (pt) 2002-10-31
NZ286232A (en) 1996-10-28
AU697908B2 (en) 1998-10-22
CN1140173A (zh) 1997-01-15
JPH08269059A (ja) 1996-10-15
TW426682B (en) 2001-03-21
SK36596A3 (en) 1997-02-05
DK0736532T3 (da) 2002-09-02
IL117621A (en) 1999-05-09
EP0736532B1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
SG43249A1 (en) Novel pyrido[3,2-e]pyrazinones with anti-asmatic action and processes for their manufacture
PL326841A1 (en) Poly (9,9'-spirodiffluorenes), their production and application
IL113912A0 (en) Thieno [1,5] benzodiazepine use
ZA942571B (en) 1,5 benzodiazepine derivatives
ZA972134B (en) Benzoxazepine compounds their production and use
HUP9900339A3 (en) Water-soluble copolymers, process for producing the same and their use
SG52950A1 (en) Process for producing polyacetal copolymer
AP9400657A0 (en) 1,5 benzodiazepine derivatives
AU6039394A (en) Process for making 1,3-diols and 3-hydroxyaldehydes
ZA972831B (en) Process for the preparation of enantiomerically pure cyclo-alkano-indol-and azaindol -and pyrimido [1,2A] indolcarbocyclic acids and their activated derivatives.
EP0761711A3 (en) Thermoplastic copolymer based on polyvinyl alcohol, process for its production and use
ZA966757B (en) Novel compounds and process.
NZ326039A (en) Process for making 3,4-dihydro-pyrimidin-2(1h)-one derivatives
AU2742397A (en) Processes for producing 1,6-hexanedials and derivatives
HUP9801716A3 (en) 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, ph
HU9601918D0 (en) N,n-diethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
ZA952526B (en) 1,2,4-triazolo[4,3-a]pyrazin-4-one derivatives and preparation thereof
HU9700628D0 (en) 4-thia-1-aza-bicyclo[3.2.0]heptan-3-imino-2-izopropiliden-7-oxo-beta-lactame derivatives, process for producing them and use of them
EP0778278B1 (de) Alkoxyformoxysilane, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
AU8701298A (en) 2,3-dihydro-benzofuranol derivatives and process for resolving the same
IL133533A0 (en) Non-immunosuppressive compounds, process for their preparation and different uses thereof
AU685960C (en) Solid solutions of pyrrolo-{3,4-c}-pyrroles with quinacridonequinones
ZA965883B (en) N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate
AU2840095A (en) Solid solutions of pyrrolo-{3,4-c}-pyrroles with quinacridonequinones
ZA965721B (en) Novel process and compounds.